Related Experiment Video
Updated: Oct 18, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome
Nandini Vijayakanthi1, Eric I Felner1, Rene Romero2
1Department of Pediatrics, Division of Endocrinology, Emory University School of Medicine, Atlanta, GA 30322, United States.
Abstract:
We report a 13-year-old female with rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome, panhypopituitarism, dyslipidemia, type 2 diabetes mellitus, and nonalcoholic fatty liver disease, who developed rhabdomyolysis and acute kidney injury, two weeks after switching from lovastatin to rosuvastatin. She had been on lovastatin for eight years without any adverse effects.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Nephrotic Syndrome I : Introduction
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Drug Excretion: Tubular Secretion
Nephrotic Syndrome II : Assessment and Medical Management
Hemodialysis II: Procedure and Complications

